Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to the risk of death and organ dysfunction. METHODS: In this randomized, placebo-controlled trial, we assigned adults who had been in the ICU for no longer than 24 hours, who had proven or suspected infection as the main diagnosis, and who were receiving a vasopressor to receive an infusion of either vitamin C (at a dose of 50 mg per kilogram of body weight) or matched placebo administered every 6 hours for up to 96 hours. The primary outcome was a composite of death or persistent organ dysfunction (defined by the use of vasopressors, invasive mechanical ventilation, or new renal-replacement therapy) on day 28. RESULTS: A total of 872 patients underwent randomization (435 to the vitamin C group and 437 to the control group). The primary outcome occurred in 191 of 429 patients (44.5%) in the vitamin C group and in 167 of 434 patients (38.5%) in the control group (risk ratio, 1.21; 95% confidence interval [CI], 1.04 to 1.40; P = 0.01). At 28 days, death had occurred in 152 of 429 patients (35.4%) in the vitamin C group and in 137 of 434 patients (31.6%) in the placebo group (risk ratio, 1.17; 95% CI, 0.98 to 1.40) and persistent organ dysfunction in 39 of 429 patients (9.1%) and 30 of 434 patients (6.9%), respectively (risk ratio, 1.30; 95% CI, 0.83 to 2.05). Findings were similar in the two groups regarding organ-dysfunction scores, biomarkers, 6-month survival, health-related quality of life, stage 3 acute kidney injury, and hypoglycemic episodes. In the vitamin C group, one patient had a severe hypoglycemic episode and another had a serious anaphylaxis event. CONCLUSIONS: In adults with sepsis receiving vasopressor therapy in the ICU, those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who received placebo. (Funded by the Lotte and John Hecht Memorial Foundation; LOVIT ClinicalTrials.gov number, NCT03680274.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review and meta-analysis of 2124 patients, with 1274 on pulmonary hypertension specific agents demonstrated only small quality of life benefits in patients with PH and IPF, thus there is insufficient evidence to support their widespread use [119].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [119]
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationAPACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
Liu, V., Escobar, G. J., Greene, J. D., Soule, J., Whippy, A., Angus, D. C., & Iwashyna, T. J. (2014) · JAMA · doi:10.1001/jama.2014.5804 · Cited by 977
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
Heyland, D., Muscedere, J., Wischmeyer, P. E., Cook, D., Jones, G., Albert, M., Elke, G., Berger, M. M., & Day, A. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212722 · Cited by 904
Self-citationHydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Fowler, A. A., Truwit, J. D., Hite, R. D., Morris, P. E., DeWilde, C., Priday, A., Fisher, B., Thacker, L. R., Natarajan, R., Brophy, D. F., et al. (2019) · JAMA · doi:10.1001/jama.2019.11825 · Cited by 836
Research works printed but not linked: 1
- Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:Suppl 1:1-38.
Cited by
Items 301–354 of 354
Pregernig, A., Held, U., Schläpfer, M., & Beck‐Schimmer, B. (2024) · Figshare · doi:10.6084/m9.figshare.26549301
Liang, B., Su, J., Shao, H., Chen, H., & Xie, B. (2024) · Figshare · doi:10.6084/m9.figshare.26574941
Nutrition in critically ill adult patients: An update
Mohan, A., Prasanth, P., Harirao, N. K. D., Harikrishna, J., Ahluwalia, S., & Ahluwalia, S. (2025) · The Journal of Clinical and Scientific Research · doi:10.4103/jcsr.jcsr_119_25
Gong, R., Huang, Z., Zhao, J., Tang, M., Mu, F., Sun, K., Cui, C., Yan, Z., & Wang, J. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12377-1
“…this result may be influenced by baseline imbalances-the treatment group had more severe conditions at enrollment, manifested as higher lac levels, a higher proportion of shock and receiving IMV [30], which likely masked the actual efficacy and even led to a conclusion biased towards being harmful.”
Adjunctive Therapies in Sepsis: Corticosteroids, IVIG, Blood Purification, and More
Ekici, H., & Türe, Z. (2025) · doi:10.59537/saupress.2500
Precision Medicine in Sepsis: From Biomarkers to Bedside
MEŞE, E. A., YÜCE, Z. T., Eren, E. E., Tufan, Z. K., Eser, F., Oktay, Z., Beder, D., Yaman, M., Altındiş, M., Baddal, B., et al. (2025) · doi:10.59537/saupress.2486
Gandini, L., Liu, K., Passmore, M. R., Chan, C. H. H., Wilson, E., Ijuin, S., Milani, A., Hyslop, K., White, N. M., Perera, B., et al. (2026) · ASAIO Journal · doi:10.1097/mat.0000000000002644
Intravenous Vitamin C in Severe Sepsis: A Systematic Review of Evidence From 2020 to 2025
Ahmed, R., Shetty, S., Khan, M. A., Kalsoom, I., Qasim, S. M., Khan, S. B., & Abdullah, S. (2026) · Cureus · doi:10.7759/cureus.100867 · Cited by 3
“…al. (LOVIT trial) conducted a large multicenter randomized placebo-controlled trial and rated it low risk using RoB-2 due to robust randomization, blinding, prespecified primary outcomes, and intention-to-treat analysis, although interpretation of adverse events requires careful consideration [17].”
InfluentialАлександрович, А. В., & Львович, П. Л. (2025) · Современные проблемы науки и образования · doi:10.17513/spno.34420
Role of Micronutrients in Perioperative Care: A Systematic Review
Banerjee, D., & Yadav, R. (2026) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-25153
“13 Selenium supplementation prevents perioperative selenium decline but has not shown consistent benefits for organ dysfunction or mortality in large RCTs, 4,14 despite observational links between low selenium and adverse outcomes.”
Sharma, Y., Mangoni, A. A., Woodman, R. J., Ng, H. S., Arthur, M., Sumanadasa, S., Bihari, S., & Thompson, C. H. (2026) · JMIR Research Protocols · doi:10.2196/91037
“…trial, which evaluated high-dose intravenous ascorbic acid in patients with sepsis who were critically ill (one-third with respiratory infection), found no significant mortality benefit, although treatment was abruptly discontinued and ascorbic acid was used rather than sodium ascorbate [14].”
InfluentialNutritional Support Strategies in Sepsis: From Pathophysiology to Clinical Practice
Bai, Z., Zheng, M., Chen, Z., Hu, X., Bie, M., Zhang, Q., Li, C., & Shi, X. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014462
Ojeda, D., Ferrer, R., Garnacho‐Montero, J., Maseda-Garrido, E., & Ochagavía, A. (2026) · Medicina Intensiva · doi:10.1016/j.medin.2026.502448
Interpreting Redox Biology in the Perioperative Setting
Elsherbini, A., Adhikari, N. K. J., & Tam, D. Y. (2026) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezag142
Self-citationZhou, F., Li, D., Liu, C., Li, Q., Hu, J., & Lu, Y. (2026) · Nutrición Hospitalaria · doi:10.20960/nh.06272
Amir, A., Minhas, M., Beyene, E., Ononenyi, C., Deverapalli, M., & Michael, M. B. (2026) · Journal of the National Medical Association · doi:10.1016/j.jnma.2026.03.007
Hibbert, E., Leggett, N. E., Kim, D., Silva, S. D., Messiha, R., Abbenbroek, B., Campbell, L. T., Deane, A., Dye, J., Eastwood, G. M., et al. (2026) · Annals of the American Thoracic Society · doi:10.1093/annalsats/aaoag102
Andaluz‐Ojeda, D., Ferrer, R., Garnacho‐Montero, J., Maseda-Garrido, E., & Ochagavía, A. (2026) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2026.502448
Refractory Shock in the Post–Cardiac Arrest Patient
Walker, A. C., & Johnson, N. J. (2026) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2026.04.003
Cancio, L. C., & Foster, K. N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-88389-4.00017-8
High-Dose Vitamin C in Burns: Time to Stop
Greenhalgh, D. G. (2026) · JAMA · doi:10.1001/jama.2026.10573
Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis
Lima, P. D. A., Yu, C., Hunt, M., Lamontagne, F., Adhikari, N. K. J., Marshall, J. G., Hindmarch, C. C. T., & Maslove, D. M. (2026) · Intensive Care Medicine Experimental · doi:10.1186/s40635-026-00924-2 · Cited by 1
Self-citationMicronutrient trials in critical illness – new evidence since 2023
Blaauw, R., & Berger, M. M. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001396 · Cited by 3
Skrifvars, M. B., Langer, T., & Greco, M. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08529-9
Farhati, V., Hunter, J., Sattwika, P. D., & Rozi, M. F. (2026) · Bali Journal of Anesthesiology · doi:10.4103/bjoa.bjoa_298_25
Vera-Ponce, V. J., Ballena-Caicedo, J., Valladolid-Sandoval, L. A. M., Zuzunaga-Montoya, F. E., Acosta-Porzoliz, R. P. E., Rivera-Lozada, O., & Valladares-Garrido, M. J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0351072
“LOVIT (n = 872) tested high-dose vitamin C monotherapy (200 mg/kg/day for 4 days) and found no mortality benefit and a possible increase in 28-day mortality and organ dysfunction in the intervention arm [16].”
Vitamin C in acute critical illness: don’t confuse pharmacotherapy and nutrition!
Rousseau, A., Pantet, O., Stoppe, C., de Man, A. M. E., & Berger, M. M. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08546-8 · Cited by 1
Nutritional Assessment of the Critically Injured Patient
Dawson-Gore, C. C., & Roberts, M. (2026) · Current Trauma Reports · doi:10.1007/s40719-026-00310-z · Cited by 1
Twichell, E., Sattler, L. A., & Reynolds, D. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001409
Hui, Z., Shen, N., Zhang, H., Yu, M., Li, Z., Ping, J., & Fu, Q. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1880883
Premer, C., Starahs, M., Hare, J. M., & Merchant, R. C. (2026) · Critical Care · doi:10.21203/rs.3.rs-10450697/v1
Lee, J. G., Sohn, Y. M., Lee, S. H., Jung, Y. T., Lee, H., Park, J. Y., Choi, N.-J., Song, J. M., Lee, J. Y., Kim, M., et al. (2026) · 한국정맥경장영양학회지 · doi:10.15747/acnm.26.0059
Zhao, B., Yu, X., Zhang, H., Yu, M., Sun, W., Zhao, F., Huang, H., Song, M., Wang, S., Ma, W., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1850105
“…no reduction in SOFA scores in sepsis-associated ARDS (22), and the LOVIT trial ( n = 872) reported that vitamin C (50 mg/kg every 6 h for up to 96 h) increased the risk of death or persistent organ dysfunction in adults with sepsis receiving vasopressor therapy (RR 1.21, 95% CI 1.04–1.40) (23).”
InfluentialDumargne, H., Ly, S. H., Louzier, V., Allaouchiche, B., Hammed, A., & Dargent, A. (2026) · Critical Care · doi:10.1186/s13054-026-06160-0
Bašković, M., & Ježek, D. (2026) · Antioxidants · doi:10.3390/antiox15081029
“…hundred and ninety-one of four hundred and twenty-nine patients given vitamin C, that is 44.5 percent, against one hundred and sixty-seven of four hundred and thirty-four given placebo, that is 38.5 percent, a risk ratio of 1.21 with a ninety-five percent confidence interval of 1.04 to 1.40 [156].”
InfluentialMicronutrients in adult critically ill patients: lessons learned and the path toward precision
Stoppe, C., Gündoğan, K., & Stefano, M. (2026) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001253 · Cited by 1
Navigating the Pendulum Swings in Surgery: Historical Shifts and Lessons for Modern Practice
Cadili, A. (2026) · Southern Medical Journal · doi:10.14423/smj.0000000000002005
Cai, B., Xiao, Q., Xia, Y., Yu, X., Xian, X., Liu, L., Dai, Y., & He, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1905726
“The research ethics board allowed the inclusion of this patient only in the primary analysis (13)].”
InfluentialKim, Y., Ko, B. S., Roh, Y., Kwon, H. J. N., Kim, S., Cha, K., Kim, Y. H., & Kim, W. Y. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104191
“26 The VITaCCA trial found no reduction in organ dysfunction after OHCA and reported worse organ-function, myocardial, renal, and neurological outcomes with the supraphysiological 10 g/day regimen.”
Han, K., Yuan, S., Yan, S., Fu, J., Wu, T., Cui, F., & Zhang, X. (2026) · Medicine · doi:10.1097/md.0000000000050682
Sepsis in the Emergency Department: An Evidence-Based Reappraisal of the “Golden Hour”
Danış, F., & Kudu, E. (2026) · Anatolian Journal of Emergency Medicine · doi:10.54996/anatolianjem.1972015
Ishiguro, M., Suzuki, Y., Kobayashi, K., Koga, R., Tsuchida, T., Hanawa, T., Shitanda, I., & Goto, S. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147751
救急領域における微量栄養素(Micronutrients in emergency care)
大輔, 室., 慶, 水., & 拓也, 北. (2026) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.13180
“12, 13, 15) Vitamin D”
Peñaloza-López, O. A., & Valencia-Herrera, A. R. (2026) · Sanitas. Revista arbitrada de ciencias de la salud. · doi:10.62574/v7nq8266
Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury
Hemilä, H., & Chalker, E. (2026) · JAMA · doi:10.1001/jama.2026.16509
Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury—Reply
Stoppe, C., Day, A. G., & Turgeon, A. F. (2026) · JAMA · doi:10.1001/jama.2026.16512
Self-citationKoca, H., & Ayvat, P. U. (2026) · Infection · doi:10.1007/s15010-026-03019-y
Rusch, S., Mester, P., Möller, F., Müller, M., & Gülow, K. (2026) · Antioxidants · doi:10.3390/antiox15101368
“The larger LOVIT trial in vasopressor-dependent sepsis found an increased composite risk of death or persistent organ dysfunction with intravenous vitamin C [122].”
Schouten, N. E., & van Zanten, A. R. H. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001455
Stefano, M., Girombelli, A., Formenti, P., & Vetrone, F. (2026) · Nutrients · doi:10.3390/nu18213516
Šantić, R., Kumrić, M., Cvitković, I., & Božić, J. (2026) · Molecules · doi:10.3390/molecules31213832
Omar, S. R. (2026) · Health Innovation Reports · doi:10.64048/hir.v2n2.005
Neue Sepsis-Leitlinien: SSC 2026 und DSG 2025 – konkurrierend oder komplementär?
Schmoch, T., Wurth, A., Theobald, V., Espeter, F., Weigand, M. A., & Brenner, T. (2026) · Die Anaesthesiologie · doi:10.1007/s00101-026-01753-4
Metadata
- Authors
- Lamontagne, F., Masse, M.-H., Menard, J., Sprague, S., Pinto, R., Heyland, D. K., Cook, D. J., Battista, M.-C., Day, A. G., Guyatt, G. H., Kanji, S., Parke, R., McGuinness, S. P., Tirupakuzhi Vijayaraghavan, B.-K., Annane, D., Cohen, D., Arabi, Y. M., Bolduc, B., Marinoff, N., Rochwerg, B., Millen, T., Meade, M. O., Hand, L., Watpool, I., Porteous, R., Young, P. J., D’Aragon, F., Belley-Cote, E. P., Carbonneau, E., Clarke, F., Maslove, D. M., Hunt, M., Chassé, M., Lebrasseur, M., Lauzier, F., Mehta, S., Quiroz-Martinez, H., Rewa, O. G., Charbonney, E., Seely, A. J. E., Kutsogiannis, D. J., LeBlanc, R., Mekontso-Dessap, A., Mele, T. S., Turgeon, A. F., Wood, G., Kohli, S. S., Shahin, J., Twardowski, P., & Adhikari, N. K. J.
- Affiliations
- Université de Sherbrooke (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Research Centre of the Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada J1H 5N4
- McMaster University (CA)
- Sunnybrook Health Science Centre (CA)
- Queen's University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Ottawa Hospital (CA)
- University of Auckland (NZ)
- Auckland City Hospital (NZ)
- Department of Critical Care Medicine, Apollo Hospitals, Chennai, India
- Inserm (FR)
- Bishop's University (CA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Juravinski Hospital (CA)
- Hamilton Health Sciences (CA)
- Ottawa Hospital Research Institute (CA)
- Apollo Hospitals (IN)
- McMaster University, Department of Medicine, Hamilton, ON, Canada L8N 3Z5
- Centre Hospitalier de l’Université de Montréal (CA)
- Université Laval (CA)
- University of Toronto (CA)
- University of Alberta (CA)
- Hôpital du Sacré-Cœur de Montréal (CA)
- University of Ottawa (CA)
- Université de Sherbrooke, Department of Medicine, Sherbrooke, QC, Canada J1H 5N4
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation Creteil, Île-de-France, FR 94000
- Western University (CA)
- Island Health (CA)
- McGill University Health Centre (CA)
- University of Otago, Department of Surgical Sciences, Dunedin, NZ 9054
- ORCID
- Lamontagne, François
- Masse, Marie-Hélène
- Sprague, Sheila
- Pinto, Ruxandra
- Heyland, Daren K.
- Battista, Marie-Claude
- Day, Andrew G.
- Guyatt, Gordon H.
- Kanji, Salmaan
- Parke, Rachael
- McGuinness, Shay P.
- Annane, Djillali
- Cohen, Dian
- Arabi, Yaseen M.
- Rochwerg, Bram
- Meade, Maureen O.
- Watpool, Irene
- Porteous, Rebecca
- Young, Paul J.
- Clarke, France
- Maslove, David M.
- Chassé, Michaël
- Lauzier, François
- Mehta, Sangeeta
- Rewa, Oleksa G.
- Charbonney, Emmanuel
- Seely, Andrew J.E.
- Kutsogiannis, Demetrios J.
- Mele, Tina S.
- Turgeon, Alexis F.
- Wood, Gordon
- Shahin, Jason
- Adhikari, Neill K.J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-06-23
- Volume
- 386
- Issue
- 25
- Pages
- 2387-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4282975062
- Cited by
- 350
- References
- 31
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 75 · 2023: 98 · 2022: 40
- FWCI
- 45.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- The Lotte & John Hecht Memorial Foundation (4318)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- intravenous vitamin C, vitamin C, vasopressor therapy, intensive care unit, mortality, organ dysfunction, acute kidney injury, hypoglycemia, anaphylaxis, sepsis treatment, critically ill adults, health-related quality of life, 6-month survival, biomarkers, organ dysfunction scores
- MeSH terms
- Adult, Ascorbic Acid, Humans, Hypoglycemic Agents, Intensive Care Units, Multiple Organ Failure, Quality of Life, Vasoconstrictor Agents, Vitamins, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.